Infuse logo

How have you already innovated in the area of data, information or digital technology?

How can this innovation be adapted to improve immunisation delivery in multiple low-income countries?

At the 2016 World Economic Forum Annual Meeting in Davos, Gavi, the Vaccine Alliance announced INFUSE – an innovation-based partner development platform.

INFUSE aims to identify the most promising innovative ideas and technologies and connect them with influential public and private sector leaders. By doing so, Gavi hopes to help facilitate the accelerated expansion of innovations that will lead to sustainable and widespread improvements – modernising immunisation delivery.

The 2016 INFUSE theme is immunisation data availability, quality, and use - three fundamental steps toward building efficient and sustainable immunisation systems in developing countries.

Developing countries need strengthened data tools and processes in order to reach under-immunised children and vulnerable populations. Knowledge gained through improved data management will enable governments to better protect against illness, outbreaks and pandemics.

Do you have an innovative data initiative with a proven track record?

Do you want your initiative to be considered for partnering with some of the world's leading decision makers and executives?

Gavi INFUSE: Innovation for uptake, scale and equity in immunisation

The goal of INFUSE is to identify the most promising innovative ideas and technologies to scale up vaccine implementation, and to infuse those ideas with political and financial capital through partnership. INFUSE 2016 is dedicated to bettering immunisation delivery in low-income countries through improved data availability, quality and use.

Gavi, the Vaccine Alliance is a multi-billion dollar global health public-private partnership that co-finances with developing countries their immunisation programmes. 60% of the children born in the world each year live in these countries. Since 2000 we have immunised over half a billion children, which will prevent 7 million deaths. By 2020 we strive to reach even further to immunise another 300 million children which will save an additional 5-6 million lives.

Gavi works hand in hand with developing country governments and our network of public and private partners – all with the shared vision of reaching every child with life-saving vaccines. Gavi has a strong track record of leveraging private sector expertise. We have encouraged greater and continued innovation in the vaccine manufacturing industry to secure sustainable vaccine supply at prices affordable for developing countries. While much progress has been made in the past 15 years, many obstacles remain when delivering vaccines to the children who need them most. We must continue to innovate and modernise delivery systems.

INFUSED INNOVATIONS – TARGETING MODERN HEALTH DELIVERY

Some of the greatest challenges facing immunisation delivery include data quality, demand generation to ensure communities are aware of the value of immunisation, capacity building of healthcare workers, and cold chain to keep vaccines at the right temperature when being shipped and stored. The challenges are vast but we believe that existing technologies can be adapted to make a significant difference. Many times the people and organisations behind the greatest ideas struggle to get access to decision-makers and funders who can take their ideas to a meaningful scale. Additionally, developing country governments are often unsure of the best technologies to adopt.

To help bridge this innovation gap Gavi is calling on entrepreneurs, corporations, and implementers to further adapt and innovate to improve vaccine delivery in some of the world’s poorest countries. A healthy future will be built on innovation-based partnerships. That is where INFUSE comes in.

How does INFUSE work?

INFUSE is about taking innovative concepts to scale through partnership. We are seeking proven concepts that could be adapted and scaled in multiple low-income settings, and not new concepts that have yet to be tested. INFUSE will gather the best and brightest ideas through an online application that is open to everyone. These applications will then be reviewed using criteria below. The most promising applicants will be invited to attend a series high profile workshops alongside leading multinational CEOs and government officials where their ideas will be further adapted, and primed for partnership. Gavi will use its convening power to encourage the development of new public-private partnerships to scale-up these adapted technologies. The deadline for initial applications is 15 March 2016.

2016 INFUSE topic: data availability, quality and usage

Gavi supports the immunisation system strengthening efforts lead by developing countries to help them achieve and maintain high immunisation coverage rates. These countries are committed to strengthening data availability, quality and use instruments and processes to build robust immunisation system infrastructure. This infrastructure is needed to reach under-immunised children, vulnerable populations and protect people from illness, outbreaks and pandemics.

How will your organisation innovate to improve immunisation delivery in low-income countries through data, information and/or digital technology?

This can be delivered through a new product or process or expansion/adaptation of existing. Proven innovations that can be adapted, applied and scaled to achieve permanent and widespread improvements in immunisation data quality, availability and usage.

Proposed solutions to be scaled might include: electronic immunisation registers, real-time data monitoring for health systems or vaccine stock, electronic cold chain monitoring, tracking solutions such as barcoding or RFID (radio frequency identification).

INFUSE: Innovation for uptake, scale and equity in immunisation

Application review

Confidentiality in INFUSE

Reviewers will evaluate applications. All reviewers will be asked to exercise the same respect for any confidential aspects of the submissions as they would in their professional activities.

  • As needed, parties involved in the review process will be asked to sign a standard confidentiality/non-disclosure agreement.

Criteria

What are the reviewers looking for?

Present and future impact
  • Does the idea demonstrate specific and measurable impact so far, and what will be the potential impact to Gavi recipient countries by 2020? (lives affected and/or efficiencies gained)
  • Has the applicant provided evidence-based impact data supporting the idea's potential value, at the proof-of-concept, small-scale or mid-scale levels?
  • Is the idea based on a clearly identifiable country need? How will it add value?
Innovation
  • How does the product and/or process design demonstrate creativity?
  • Is there demonstrated innovation in the delivery mechanism, business model or partnership process?
  • What consideration have you given to alternative approaches to implement the idea?
Technical feasibility
  • Has technical feasibility been clearly demonstrated?
  • How have you identified and addressed potential risks of your new product or process?
  • Is your initiative targeting the right partners for delivery?
Viability
  • Does the idea suggest an attractive business model, and does it meet the market needs of Gavi, national governments, local government, and health centres?
  • Give evidence that the idea can be scaled and adapted to a variety of country scenarios.
  • Do you have a strategy for achieving scale? Does the product or process have a competitive advantage? Is there market data demonstrating the sustainability of the business model?
  • Why will your idea attract private sector investment and partnership?
Clarity and proof of concept
  • Do you have evidence to back up the need?
  • Is your application convincing and well-organised?
  • Does the idea have a proven track record at a national or state level in a developing country?
  • Does it demonstrate potential for replication in other countries or regions?

Frequently Asked Questions

  • What is INFUSE?

    INFUSE — innovation for uptake, scale and equity in immunisation — is a new partner development platform aimed at enabling scalable collaborations between local or global entrepreneurs and implementers, multi-national corporations, and developing country governments to modernise the way we deliver vaccines to children in the world’s poorest countries.

  • What is the 2016 topic area?

    The 2016 topic area is data availability, quality, and use.

  • How does INFUSE work?

    INFUSE will gather the best and brightest ideas through an online application. These applications will then be reviewed according to the stated criteria. The most promising applicants will be invited to attend a series high profile workshops alongside leading multinational CEOs and government officials where their ideas will be further adapted, refined, and primed for partnership. Gavi will use its convening power and global influence to encourage the development of exciting new public-private partnerships to scale these adapted technologies across multiple countries. Benefits of participation could include media exposure, connections with political leaders and access to funding through new partnerships.

  • When can I apply?

    INFUSE will accept applications starting on 22 January 2016.

  • How do I apply?

    The short application process starts with online registration on the INFUSE platform website.

  • Can I submit a proposal that is still in the idea phase?

    Ideas must have a proof-of concept which is ready to be scaled. New ideas which have not yet been developed or piloted are not eligible.

  • Can individuals apply?

    INFUSE is open only to established organisations that already have relevant operational experience and proof of concept for their proposal.

  • Can we apply collectively as a team?

    Yes, up to 5 team members can be assigned to the same application.

  • How will INFUSE operate?

    The platform will accept registrations starting on 22 January 2016. The application process begins with online registration on the INFUSE platform website. There will be two rounds of evaluation with a workshop in between.

  • How will entries be reviewed?

    See review criteria link

  • INFUSE benefits?

    Benefits of participation can include media exposure, connections with political leaders and access to funding through new partnerships.

  • How much will it cost to apply?

    Registration fees for this year have all been waived. Applicants will be responsible for covering their own costs for developing their proposals.

  • Is this open to private companies / NGOs / Research organisations?

    The initiative is open to any organisation. Gavi employees cannot apply.

  • Who is Gavi?

    Launched in 2000 at the World Economic Forum in Davos, Gavi is a global Vaccine Alliance, bringing together public and private sectors with the shared goal of creating equal access to new and underused vaccines for children living in the world’s poorest countries. Gavi.org

  • Why is Gavi doing this?

    INFUSE seeks to complement the greater global health development landscape by identifying and enabling scalable and adaptable operating models across different countries. INFUSE is a mechanism that seeks to capture new opportunities for innovation by connecting entrepreneurs and technology solutions with the right markets and private sector partners to achieve scale. Enabling the adaptation of selected interventions will unlock enormous benefits across the broader health development landscape — contributing significant impact by bringing effective and sustainable health systems to millions more.

  • How will I know that my application was submitted successfully?

    You will receive a submission success email response with a tracking number.

  • I'm having problems with the site, who should I contact?

    infuse@gavi.org

  • To whom should we direct questions about INFUSE?

    infuse@gavi.org

INFUSE: Terms and Conditions

Please read these rules, terms and conditions carefully. By applying to INFUSE you acknowledge and agree to these rules, terms and conditions.

  1. The initiative is open to applications from private sector, NGO, and public sector organisations. Gavi employees are not eligible to participate in INFUSE.
  2. Proposals will be reviewed by a review panel that may include representatives from multinational corporations, venture capitalists and donor agencies.
  3. Selected applications will be based on merit.
  4. Content, representations and ideas presented during the review process may be published and shared with Gavi’s strategic partners who can help advance efforts to scale immunisation solutions.
  5. An expert panel will review applications. All decisions made by the reviewers will be considered final.
  6. Any form of plagiarism will result in forfeiture of eligibility.
  7. Selected partnerships will be posted on the event portal after announcements are made at WEF Davos 2017.
  8. By entering, applicants agree to participate in such promotional activity and material as Gavi and its partners may request. This includes but is not limited to the use of photographs, videos and testimonials.
  9. Funding is not guaranteed to applicants.
  10. This initiative is being run by Gavi, the Vaccine Alliance. Gavi brings together public and private sectors with the shared goal of creating equal access to new and underused vaccines for children living in the world’s poorest countries.

Please read our Privacy Policy which tells you how we use any personal information, we may collect about you by entering a competition.

Gavi reserves the right to amend these rules at any time; if it does so, it will post an update on its website and notify all participants. Gavi may also create rules which may only apply to a specific competition. If this occurs, Gavi will publish the amended competition rules and/or specific competition rules on the relevant competition page.

Competition Management Software